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Abstract
Aim Advanced stage presentation of colorectal cancer is
associated with poorer survival outcomes, particularly
among young adults. This study aimed to determine
whether demographic risk factors for advanced stage
presentation differed between young and older adults.
Method Individual-level data on all incident colorectal
cancers in people aged 20 years and above were
extracted from the National Cancer Registration and
Analysis Service database for the years 2012 to 2015.
Patients were divided into two cohorts: young-onset
colorectal cancer (YOCC) if aged 20–49 years and
older-onset colorectal cancer (OOCC) if aged 50 years
and above. Logistic regression was used to identify risk
factors for advanced stage presentation, defined as
TNM Stage III or IV, in each cohort.
Results There were 7075 (5.2%) patients in the YOCC
cohort and 128 345 (94.8%) patients in the OOCC
cohort. Tumours in the YOCC cohort were more likely
to be at an advanced stage (67.2% vs 55.3%, P < 0.001)
and located distally (63.7% vs 55.4%, P < 0.001). No
demographic factor was consistently associated with
advanced stage presentation in the YOCC cohort.
Among the OOCC cohort, increased social deprivation
[OR (Index of Multiple Deprivation quintile 5 vs
1) = 1.11 (95% CI 1.07–1.16), P < 0.001], Black/
Black British ethnicity [OR (baseline White) = 1.25
(95% CI 1.11–1.40), P < 0.001] and residence in the
East Midlands [OR (baseline London) = 1.11 (95% CI
1.04–1.17), P = 0.001] were associated with advanced
stage presentation.
Conclusion Demographic factors associated with
advanced disease were influenced by age. The effects of
social deprivation and ethnicity were only observed in
older adults and mirror trends in screening uptake. Tar-
geted interventions for high-risk groups are warranted.
Keywords Colorectal neoplasms, demography, risk fac-
tors, age distribution, socioeconomic factors, ethnic
groups
What does this paper add to the literature?
Demographic risk factors for advanced stage presenta-
tion of colorectal cancer are not well described in the
UK. Although younger age was associated with more
advanced and distal disease, inequalities related to
socioeconomic status and ethnicity were only noted in
older adults and reflect similar trends in screening
uptake.
Introduction
In England, colorectal cancer (CRC) is the third most
common cancer in men and women and accounts for
35 000 new diagnoses each year [1]. While overall age-
standardized incidence rates of CRC have remained
stable in the UK [2,3], this trend masks recent changes
in age-specific incidence rates. There is a substantial
body of evidence to suggest that the incidence of CRC
in adults under 50 years is rapidly increasing in England
and other nations with a high human development
index (HDI) [4–9], although the cause of this increase
is not well understood and is thought to be associated
with a rising prevalence of obesity, adoption of seden-
tary lifestyles and changes to the gut microbiome [10–
13]. Conversely, recent studies from the United States
have shown a decline in incidence rates in adults aged
over 50 years that has largely been attributed to the
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introduction of screening [5,14,15].There is emerging
evidence that young-onset and older-onset CRC may in
fact be biologically distinct entities. Despite a higher
prevalence of hereditary syndromes in young-onset
CRC, most tumours are sporadic in nature and typically
located distally [16], display microsatellite stability and
are CpG island methylator phenotype-low [17–19].
Advanced stage presentation is associated with worse
survival outcomes, with 5-year net survival in England
ranging from 10.3% in Stage IV disease to 91.7% in
Stage I disease [20]. Population-based studies in other
nations with a high HDI have shown that younger age,
social deprivation and Black ethnicity are associated with
advanced stage CRC [21–25], but demographic risk
factors have not been explored in detail and it is
unknown whether these risk factors differ between
young and older adults. In the UK, there is scant evi-
dence regarding the association between demographic
factors, such as socioeconomic status (SES) and ethnic-
ity, and advanced stage presentation due to a lack of
complete data in nationally curated cancer registries
until recently [26]. Take-up of the Bowel Cancer
Screening Programme (BCSP) in England is known to
be reduced in men, more deprived socioeconomic
groups and areas of increased ethnic diversity [27], but
how these trends are reflected in the stage at presenta-
tion of the screening age population has yet to be
demonstrated. Identifying the demographic factors asso-
ciated with advanced stage presentation is of critical
importance as it would help guide targeted interven-
tions at a population level.
Therefore, the aim of this study was to determine
whether demographic risk factors for advanced stage
presentation of CRC differed between young and older
adults in the English population using data from the
National Cancer Registration and Analysis Service
(NCRAS) from 2012 to 2015 inclusive.
Method
This study was reported according to the STROBE
guidelines for epidemiological studies (Table S1 in the
online Supporting Information) [28]. Data were
obtained on all patients aged 20 years and above from
2012 to 2015 using data from the National Cancer
Registration and Analysis Service (NCRAS) (request ID
ODR1718_067). NCRAS is the population-based can-
cer registry for England, operated by Public Health
England, which collects, quality assures and analyses
data on all patients with cancer in the English popula-
tion. NCRAS receives data from multiple sources across
the National Health Service including multidisciplinary
team (MDT) meetings, pathology reports, molecular
testing results, treatment records, hospital activity
records, hospital patient administration systems and
operational standards, such as cancer waiting times, to
ensure complete coverage [26].
Procedures
All new diagnoses of CRC were identified using the
ICD10 codes for colonic (C18.1, C18.2-C18.9), rec-
tosigmoid (C19) and rectal (C20) tumours. Appen-
diceal tumours (C18.1) were excluded due to their
differing aetiology. Patients diagnosed prior to 2012
were not included because of the high level of incom-
pleteness for stage and ethnicity data.
Patients diagnosed when under 50 years of age com-
prised the young-onset colorectal cancer (YOCC)
cohort and patients diagnosed when aged 50 years or
above comprised the older-onset colorectal cancer
(OOCC) cohort. Patients were further stratified accord-
ing to gender, anatomical subsite (proximal – caecum
to descending colon; distal – sigmoid to rectum), geo-
graphical region, Index of Multiple Deprivation (IMD)
quintile and ethnic group. The same anatomical subsite
definition was used as in a previous study by the authors
to ensure consistency [4]. The IMD is an area-based
metric that combines weighted information on the fol-
lowing seven domains: income, employment, education,
health, crime, barriers to housing and services and the
living environment. England is divided into 32 844
lower-layer super output areas (LSOAs), each of which
is ascribed a score based on these domains. The LSOAs
are then ranked from least to most deprived and divided
into five equal groups or quintiles (1, least deprived; 5,
most deprived). Ethnicity was categorized according to
the harmonized ethnic group categories for England
used by the Office of National Statistics [29].
Tumours were staged as Union for International
Cancer Control Stage I to IV based on the TNM classi-
fication system. Coding changes between subsequent
editions of the TNM system affected sub-classifications
within individual stages (e.g. Stage IIIA, IIIB), but not
the broader stage categorization used in this study.
Staging information inputted into the NCRAS registry
was obtained from MDTs, pathology reports, imaging
results and post mortems to determine a single anatom-
ical stage at diagnosis [26]. The primary outcome of
advanced stage presentation was defined as Stage III or
IV disease at diagnosis.
Statistical analysis
Categorical data were presented as frequencies and
percentages. Unadjusted comparisons between
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variables were made using the chi-square test for
independence and the chi-square test for trend as
appropriate. Logistic regression models based on com-
plete case analysis were constructed with stage as the
dependent variable, dichotomized as early (Stage I/II)
or advanced (Stage III/IV), for the YOCC and
OOCC cohorts. Given the exploratory nature of the
study in determining potential risk factors for
advanced stage presentation, all predictor variables
were included in the regression models. The potential
modifying effect of SES on the association between
ethnicity and stage at presentation was explored using
the chi-square test for heterogeneity of ORs for unad-
justed estimates and the likelihood ratio test for inter-
action between ethnic group and IMD quintile for
adjusted estimates derived by logistic regression. The
robustness of the findings from the main analysis was
assessed using sensitivity analyses with different defini-
tions of advanced stage disease, i.e. Stage I/II/III
versus IV or Stage I versus Stage II/III/IV. Potential
bias arising from missing stage information was
assessed using multiple imputation under the assump-
tion that stage data were missing at random. The
same predictor variables were included in the imputa-
tion models as in the original regression analyses
using 20 imputed data sets. All analyses were con-
ducted using STATA 13.0 (StataCorp. 2014, Stata
Statistical Software, Release 13, StataCorp LP, College
Station, Texas, USA).
Results
The YOCC cohort accounted for 7075 of 135 420
(5.2%) new cases of CRC diagnosed between 2012
and 2015 in adults aged over 20 years. Data were
100% complete for each of the predictor variables.
Stage data were missing in 715 of 7075 patients
(10.1%) in the YOCC cohort and in 18 234 of
128 345 patients (14.2%) in the OOCC cohort.
Patients in the YOCC cohort were more likely to be
female (47.5% vs 43.9%, P < 0.001), of non-White
ethnicity (18.3% vs 8.3%, P < 0.001), less affluent
(IMD quintiles 1 and 2: 39.6% vs 45.5%, P < 0.001)
and to live in London (15.6% vs 8.8%, P < 0.001)
than patients in the OOCC cohort (Table 1).The
YOCC cohort was more likely than the OOCC cohort
to present with advanced stage disease (60.5% vs
47.4%, P < 0.001) and with tumours located in the
distal colorectum (63.7% vs 55.4%, P < 0.001). The
proportion of advanced stage presentations reduced
with increasing age, particularly among patients aged
60–79 years, for both proximal (P < 0.001) and distal
tumours (P < 0.001; Figs 1 and 2).
Risk factors for advanced stage presentation in the
YOCC cohort
Among the YOCC cohort, other/not specified ethnic-
ity (OR = 0.81, 95% CI 0.66–1.00, P = 0.045) com-
pared with White ethnicity and residence in the East
of England (OR = 0.76, 95% CI 0.62–0.94,
P = 0.010) compared with London were indepen-
dently associated with reduced likelihood of advanced
stage presentation in the main analysis (Table 2). The
effect of ethnicity on advanced stage presentation was
consistent across all IMD quintiles for each ethnic
group (Table S2). Multiple imputation for missing
stage data revealed minimal differences in effect esti-
mates for any of the predictor variables compared with
the main analysis (Table S3). However, none of the
predictor variables were consistently associated with
advanced stage presentation when using alternative
cut-offs for this outcome in the sensitivity analysis
(Tables S4 and S5).
Risk factors for advanced stage presentation in the
OOCC cohort
Advanced stage presentation was associated with
Black/Black British (OR = 1.25, 95% CI 1.11–1.40,
p < 0.001) or other/not specified ethnicity
(OR = 1.07, 95% CI 1.01–1.14, P = 0.015) compared
with White ethnicity, increasing levels of social depriva-
tion (OR (IMD quintile 5 vs 1) = 1.11, 95% CI 1.07–
1.16, P < 0.001] and residence in the East Midlands
(OR = 1.11, 95% CI 1.04–1.17, P = 0.001) compared
with London in the main analysis (Table 3). Com-
pared with patients aged 50–59 years, patients in each
of the age categories between 60 and 89 years were
less likely to present with advanced stage disease (all
P < 0.001). The likelihood of advanced stage presenta-
tion was also reduced among patients living in York-
shire and The Humber (OR = 0.94, 95% CI 0.89–
1.00, P = 0.042), the South West (OR = 0.88, 95%
CI 0.84–0.93, P < 0.001) and the East of England
(OR = 0.91, 95% CI 0.87–0.96, P = 0.001) compared
with London, and among patients with distal tumours
(OR = 0.89, 95% CI 0.87–0.92, P < 0.001). The
effect of ethnicity on advanced stage presentation was
not modified by IMD quintile for Black/Black British,
Asian/Asian British and Mixed ethnicity compared
with White ethnicity (Table S6). There was evidence
of a deprivation gradient for other/not specified eth-
nicity (P = 0.051) in the unadjusted analysis, but this
did not reach statistical significance and interaction
between ethnicity and IMD quintile was not demon-
strated in the adjusted analysis. Effect estimates
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remained largely unchanged in the multiple imputation
model for missing stage data (Table S7), except for a
reduced likelihood of advanced stage presentation in
patients aged ≥ 90 years compared with 50–59 years
(OR = 0.84, 95% CI 0.78–0.90, P < 0.001) and resi-
dence in the South East (OR = 0.95, 95% CI 0.90–
0.99, P = 0.030) compared with London. The
strength and direction of the associations between
advanced stage presentation and age, level of social
deprivation, geographical region and tumour location
remained consistent in both the regression models in
the sensitivity analysis (Tables S6 and S7). The associa-
tion between Black/Black British or other/not speci-
fied ethnicity and advanced stage presentation persisted
in the regression model with Stages I/II/III versus
Stage IV as the outcome (Table S8), but not Stage I
versus Stages II/III/IV (Table S9).
Discussion
This is the largest study based on English cancer reg-
istry data to explore risk factors associated with
advanced stage presentation of any cancer type. It is
unique in being the first study from the UK to demon-
strate evidence of socioeconomic and ethnic inequalities
in the stage at presentation of CRC. Young adults com-
prised only a small proportion of new diagnoses of
CRC but were more likely to present with advanced dis-
ease than older adults. Furthermore, they were more
likely to present with distal tumours, supporting the
findings of other smaller cohort studies that there may
in fact be biological differences between young and
older onset disease [17–19].Of note, demographic risk
factors associated with advanced stage presentation dif-
fered between the YOCC and OOCC cohorts. Among
Table 1 Demographic characteristics of the young-onset and older-onset colorectal cancer cohorts.
Characteristic
Young-onset colorectal
cancer (n, %)
Older-onset colorectal
cancer (n, %) P-value
Gender
Female 3360 (47.5) 56 373 (43.9) < 0.001
Male 3715 (52.5) 71 972 (56.1)
Ethnicity
White 5778 (81.7) 117 635 (91.7) < 0.001
Black/Black British 255 (3.6) 1517 (1.2)
Asian/Asian British 431 (6.1) 2127 (1.7)
Mixed 71 (1.0) 310 (0.2)
Other/not specified 540 (7.6) 6756 (5.3)
Index of Multiple Deprivation quintile
1 1363 (19.3) 29 144 (22.7) < 0.001
2 1438 (20.3) 29 276 (22.8)
3 1418 (20.0) 27 102 (21.1)
4 1494 (21.1) 23 687 (18.5)
5 1362 (19.3) 19 136 (14.9)
English region
London 1102 (15.6) 12 602 (9.8) < 0.001
North West 948 (13.4) 18 099 (14.1)
Yorkshire and The Humber 609 (9.5) 12 633 (9.8)
North East 318 (4.5) 6982 (5.4)
West Midlands 740 (10.5) 14 161 (11.0)
East Midlands 590 (8.3) 11 394 (8.9)
South West 744 (10.5) 15 539 (12.1)
East of England 781 (11.0) 15 015 (11.7)
South East 1183 (16.7) 21 920 (17.1)
Tumour location
Proximal 2568 (36.3) 57 239 (44.6) < 0.001
Distal 4507 (63.7) 71 106 (55.4)
UICC Stage
I/II 2083 (29.4) 49 248 (38.4) < 0.001
III/IV 4277 (60.5) 60 863 (47.4)
Missing 715 (10.1) 18 234 (14.2)
ª 2020 The Authors. Colorectal Disease published by John Wiley & Sons Ltd on behalf of Association of Coloproctology of Great Britain and Ireland4
Demographic risk factors for advanced colorectal cancer A. C. Chambers et al.
the OOCC cohort, increasing social deprivation, Black/
Black British ethnicity and residence in the East Mid-
lands were strongly associated with advanced stage pre-
sentation, and these findings remained robust to the
alternative definitions of advanced stage in the sensitiv-
ity analysis. Risk factors for advanced stage presentation
were less consistent across the main and sensitivity anal-
yses in the YOCC cohort, with no difference in risk
associated with SES, ethnicity and geographical region.
The negative association between age and stage at
presentation is well described, and was again demon-
strated in this study for both proximal and distal
tumours [21,25]. Reasons for advanced stage presenta-
tion in young adults remain unclear, despite the
increased prevalence of hereditary tumours in this group
[30]. Recent cohort studies suggest that while young
adults experience a longer time to diagnosis than older
adults this delay does not entirely explain the increased
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Figure 1 Proximal tumours: proportion of advanced stage presentation, defined as TNM Stage III or IV, by age category (com-
plete case analysis). The dashed red line refers to the overall proportion of advanced stage presentations.
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Figure 2 Distal tumours: proportion of advanced stage presentation, defined as TNM Stage III or IV, by age category (complete
case analysis). The dashed red line refers to the overall proportion of advanced stage presentations.
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risk of advanced stage presentation and that biological
factors may play a role [31]. Among the OOCC cohort,
adults of screening age were the least likely to present
with advanced disease, which may indicate the effect of
screening on this population. This would support the
findings from the initial randomized controlled trials of
faecal occult blood testing that demonstrated a shift to
earlier stage disease at presentation among participants
in the screening arms [32,33].
The deprivation gradient associated with advanced
stage presentation has been reported in other HDI
nations [22,23], although this relationship was not
demonstrated by previous studies conducted in the UK
[34,35]. In this study, there was clear evidence of a
deprivation gradient among the OOCC cohort but not
the YOCC cohort, implying that age is an effect modi-
fier in the relationship between SES and stage. Studies
where analyses have been stratified by age report con-
flicting results. A population-based study from Florida
demonstrated a deprivation gradient in both young and
older adult cohorts [36]; whereas a New Hampshire
study identified college-level education to be a risk fac-
tor for advanced stage presentation in young adults, but
protective in older adults [37]. In the current study, the
deprivation gradient among the OOCC cohort mirrors
the deprivation gradient observed in screening uptake in
England [27]. This may explain the lack of association
between SES and stage in previous studies from the
UK, as these were based on data collected prior to, or
during the initial phase of, the screening programmes in
England and Scotland [34,35].Despite only small differ-
ences in the absolute risk of advanced stage presentation
across IMD quintiles, elimination of the deprivation
gradient would have resulted in the diagnosis of about
Table 2 Logistic regression model of demographic factors associated with advanced stage presentation, defined as Stages I/II ver-
sus Stages III/IV, in the young-onset colorectal cancer cohort.
Characteristic
Early: Stages
I/II (n, %)
Advanced: Stages
III/IV (n, %)
Adjusted OR
(95% CI) P-value
Age (years)
20–29 103 (29.9) 242 (70.1) 1
30–39 489 (31.0) 1090 (69.0) 0.95 (0.73–1.22) 0.664
40–49 1491 (33.6) 2945 (66.4) 0.83 (0.65–1.06) 0.135
Gender
Female 987 (32.5) 2053 (67.5) 1
Male 1096 (33.0) 2224 (67.0) 0.98 (0.88–1.09) 0.678
Ethnicity
White 1700 (32.3) 3556 (67.7) 1
Black/Black British 80 (34.8) 150 (65.2) 0.82 (0.62–1.10) 0.189
Asian/Asian British 129 (33.7) 254 (66.3) 0.86 (0.69–1.08) 0.195
Mixed 17 (27.9) 44 (72.1) 1.16 (0.66–2.03) 0.617
Other/not specified 157 (36.5) 273 (63.5) 0.81 (0.66–1.00) 0.045
Index of Multiple Deprivation quintile
1 393 (33.2) 790 (66.8) 1
2 429 (33.0) 872 (67.0) 1.01 (0.85–1.19) 0.945
3 431 (33.9) 842 (66.1) 0.97 (0.82–1.14) 0.692
4 445 (32.6) 922 (67.4) 1.01 (0.86–1.20) 0.884
5 385 (31.2) 851 (68.8) 1.08 (0.90–1.29) 0.413
English region
London 302 (31.2) 665 (68.8) 1
North West 275 (31.9) 587 (68.1) 0.94 (0.76–1.15) 0.540
Yorkshire and The Humber 207 (33.1) 418 (66.9) 0.89 (0.71–1.11) 0.315
North East 99 (33.3) 208 (66.7) 0.92 (0.70–1.23) 0.589
West Midlands 193 (29.1) 470 (70.9) 1.09 (0.87–1.36) 0.454
East Midlands 162 (31.8) 347 (68.2) 0.96 (0.75–1.21) 0.716
South West 236 (34.6) 446 (65.6) 0.83 (0.67–1.03) 0.095
East of England 274 (37.0) 467 (63.0) 0.76 (0.62–0.94) 0.010
South East 335 (33.4) 669 (66.6) 0.89 (0.73–1.08) 0.235
Tumour location
Proximal 749 (32.0) 1590 (68.0) 1
Distal 1334 (33.2) 2687 (66.8) 0.96 (0.86–1.07) 0.437
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320 fewer cases of advanced stage disease in the OOCC
cohort annually. The absence of a deprivation gradient
in the YOCC cohort is difficult to explain, although it
does reflect the findings from a recent study of demo-
graphic trends in the incidence of young-onset CRC in
England that showed increases in the incidence rate in
CRC to be similar across all IMD quintiles [4].
In the OOCC cohort, Black/Black British ethnicity
was associated with a 25% increase in the odds of
advanced stage presentation compared with White eth-
nicity. This may represent an underestimate as Black
ethnicity is more frequently misclassified than White
ethnicity and may explain why other/not specified
ethnicity was also associated with an increase in the
odds of advanced stage presentation [38]. In the USA,
the association between Black ethnicity and advanced
stage presentation is well described and does not
appear to be modified by age [24,36]. Paradoxically,
other/not specified ethnicity was shown to be protec-
tive for advanced stage presentation in the YOCC
cohort. This finding cannot be readily explained and
may be the result of type 1 error as the associated P-
value was only just below the 5% threshold for statisti-
cal significance. In the UK, Black and minority ethnic-
ity is linked to poorer health outcomes in older adults
[39,40], although the effect of ethnicity on stage at
Table 3 Logistic regression model of demographic factors associated with advanced stage presentation, defined as Stages I/II ver-
sus Stages III/IV, in the older-onset colorectal cancer cohort.
Characteristic
Early: Stage
I/II (n, %)
Advanced: Stage
III/IV (n, %)
Adjusted OR
(95% CI) P-value
Age (years)
50–59 5037 (37.3) 8477 (62.7) 1
60–64 5784 (44.9) 7111 (55.1) 0.73 (0.70–0.77) < 0.001
65–69 7623 (46.0) 8960 (54.0) 0.70 (0.67–0.73) < 0.001
70–74 8598 (47.2) 9631 (52.8) 0.66 (0.63–0.69) < 0.001
75–79 8610 (46.5) 9920 (53.5) 0.68 (0.65–0.71) < 0.001
80–89 12 159 (45.8) 14 398 (54.2) 0.70 (0.68–0.73) < 0.001
90+ 1437 (37.8) 2366 (62.2) 0.97 (0.90–1.04) 0.385
Gender
Female 21 207 (44.7) 26 253 (55.3) 1
Male 28 041 (44.8) 34 610 (55.2) 1.02 (0.99–1.04) 0.179
Ethnicity
White 45 670 (44.9) 55 960 (55.1) 1
Black/Black British 495 (36.9) 845 (63.1) 1.25 (1.11–1.40) < 0.001
Asian/Asian British 816 (43.9) 1044 (56.1) 0.97 (0.88–1.06) 0.489
Mixed 123 (44.1) 156 (55.9) 0.98 (0.77–1.25) 0.888
Other/not specified 2144 (42.9) 2858 (57.1) 1.07 (1.01–1.14) 0.015
Index of Multiple Deprivation quintile
1 11 528 (45.9) 13 569 (54.1) 1
2 11 460 (45.5) 13 756 (54.6) 1.02 (0.99–1.06) 0.259
3 10 374 (44.7) 12 814 (55.3) 1.05 (1.01–1.09) 0.009
4 8919 (44.1) 11 317 (55.9) 1.07 (1.03–1.11) 0.001
5 6967 (42.6) 9407 (57.4) 1.11 (1.07–1.16) < 0.001
English region
London 4582 (43.1) 6050 (56.9) 1
North West 6939 (43.6) 8984 (56.4) 1.02 (0.97–1.07) 0.484
Yorkshire and The Humber 5042 (45.6) 6028 (54.4) 0.94 (0.89–1.00) 0.042
North East 2838 (45.1) 3455 (54.9) 0.95 (0.89–1.01) 0.102
West Midlands 5274 (42.9) 7029 (57.1) 1.05 (0.90–1.10) 0.097
East Midlands 3767 (41.8) 5249 (58.2) 1.11 (1.04–1.17) 0.001
South West 6487 (47.4) 7208 (52.6) 0.88 (0.84–0.93) < 0.001
East of England 6285 (46.5) 7222 (53.5) 0.91 (0.87–0.96) 0.001
South East 8034 (45.5) 9638 (54.5) 0.96 (0.91–1.01) 0.078
Tumour location
Proximal 21 008 (43.5) 27 334 (56.5) 1
Distal 28 240 (45.7) 33 529 (54.3) 0.89 (0.87–0.92) < 0.001
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presentation for any cancer type has never been stud-
ied due to historically low levels of completeness of
ethnicity data in English cancer registries [26]. The
increased risk of advanced stage presentation among
adults of Black/Black British ethnicity in the OOCC
cohort may be attributed to screening behaviour, as
screening uptake is known to be lower in areas of
increased ethnic diversity [27]. However, advanced
stage presentation was not associated with Asian/Asian
British or Mixed ethnicity, indicating that other fac-
tors, such as lifestyle or diet, may offset the risk attrib-
uted to low screening uptake in these ethnic groups.
There was no evidence that deprivation modified the
effect of Black/Black British ethnicity on advanced
stage presentation in either the YOCC or OOCC
cohorts. In the OOCC cohort, this suggests that the
increased risk of advanced stage presentation among
adults of Black/Black British ethnicity could have been
related to similarly low levels of screening uptake
across all IMD quintiles, but also to potential differ-
ences in tumour biology compared with other ethnici-
ties that predisposed to more rapid disease
progression. Evidence for genetic differences conferring
adverse outcomes in Black patients is limited to one
small retrospective study and merits further investiga-
tion [41].
The geographical variation in advanced stage presen-
tation was most pronounced in the OOCC cohort. Res-
idence in the East Midlands was a risk factor for
advanced stage presentation, whereas residence in the
South West and East of England was shown to be pro-
tective. It is difficult to reconcile the increased risk asso-
ciated with residence in the East Midlands with regional
screening uptake rates, as first-time uptake is known to
be higher in the East Midlands compared with the base-
line reference region of London [27]. A recent report
from the National Cancer Intelligence Network sug-
gests that the most likely cause of geographical variation
in stage at presentation for all cancers is the complete-
ness of stage data [42]. Regions with the highest stage
completeness reported the highest proportion of early
stage disease, with Trent (now East Midlands) reporting
the lowest proportions of stage completeness and early
stage disease [42]. In the current study, it is noteworthy
that the East Midlands also had the lowest stage com-
pleteness of all the English regions at 79.2%, compared
with 85.8% for the entire OOCC cohort (data not
shown), although stage completeness was similarly low
in the South East (80.6%) with no associated increase in
the risk of advanced stage presentation. Also, multiple
imputation was used to minimize bias associated with
missing data and the effect estimates from the multiple
imputation models were essentially unchanged from
those obtained in the main analysis. Thus, variation in
stage completeness by region may not have had a signif-
icant effect on stage at presentation.
The key strengths of this study are the size and com-
pleteness of the dataset, which has allowed the first
national-level analysis of predictors for advanced stage
presentation of CRC to be undertaken in England. How-
ever, there are some important limitations. This study
was exploratory in nature and not powered to detect a
prespecified difference in outcome for a given predictor
variable. The YOCC cohort was large (n = 7075), but
considerably smaller than the OOCC cohort
(n = 128 345) and therefore more susceptible to type II
error. Combining the data presented here with other
international datasets would reduce the impact of type II
error, but the benefits of doing so would have to be
weighed against the potential heterogeneity introduced
by including data from countries where data may be less
complete, or less accurate, and healthcare systems do not
provide universal coverage. Another limitation is that
IMD, geographical region and ethnicity are all group-
level metrics that do not fully account for individual-level
contextual factors that may have influenced the associa-
tion between these variables and stage at presentation.
Furthermore, non-White ethnicity is more likely to be
misclassified than White ethnicity and thus the effect esti-
mates of ethnic group on stage at presentation should be
viewed with caution [38].
In summary, young adults with CRC are more likely
to present with advanced disease and distal tumours than
older adults. Demographic factors associated with
advanced stage presentation differ between young and
older populations. There is clear evidence of a deprivation
gradient and increased risk of advanced stage presenta-
tion associated with Black/Black British ethnicity in older
adults that is not observed in the young, which reflect
similar patterns in screening uptake. The rising incidence
of CRC in young adults in England is characterized by a
strong cohort effect with the increased risk observed in
the youngest cohorts, i.e. those aged 20–29 and 30–
39 years, likely to be carried forward as they age [4].
More than 60% of all tumours among adults aged 50–
59 years were Stage III/IV at presentation and this age
group is likely to face the dual burden of rising CRC inci-
dence and advanced stage presentation unless the screen-
ing age is lowered. The Bowel Scope Screening
Programme, which commenced in 2013, offers a one-off
flexible sigmoidoscopy at the age of 55 years, but only
covers half of all general practice populations in England
and has the lowest uptake in the most deprived and ethni-
cally diverse areas [43,44]. Therefore, strategies that are
specifically tailored to groups at the highest risk of
advanced stage presentation are warranted. These should
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involve a more nuanced approach to the use of quantita-
tive faecal immunohistochemical testing (qFIT), which
has already been shown to increase screening uptake
among previous nonresponders [45]. Broadening access
to diagnostic endoscopy has significant resource implica-
tions in the current healthcare climate and qFIT should
be used as a risk stratification tool in symptomatic
younger patients.
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online version of this article:
Table S1. STROBE checklist.
Table S2. Risk of advanced stage presentation, defined
as Stage I/II versus Stage III/IV, by ethnic group and
stratified by Index of Multiple Deprivation (IMD) quin-
tile in the young-onset colorectal cancer cohort. aAd-
justed for age, gender, English region and tumour
location. bThe chi-square test for heterogeneity of odds
ratios was used to assess for interaction in the unad-
justed analysis of ethnicity stratified by IMD quintile for
each ethnic group. The likelihood ratio test was used to
assess interaction in the adjusted analysis by comparing
logistic regression models with and without an interac-
tion term for ethnicity–IMD quintile and thus, only
one P-value has been presented.
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Table S3. Logistic regression model of demographic
factors associated with advanced stage presentation,
defined as Stages I/II versus Stages III/IV, in the
young-onset colorectal cancer cohort after multiple
imputation of stage.
Table S4. Logistic regression model of demographic
factors associated with advanced stage presentation,
defined as Stages I/II/III versus Stage IV, in the
young-onset colorectal cancer cohort.
Table S5. Logistic regression model of demographic
factors associated with advanced stage presentation,
defined as Stage I versus Stages II/III/IV, in the
young-onset colorectal cancer cohort.
Table S6. Risk of advanced stage presentation, defined
as Stages I/II versus Stages III/IV, by ethnic group
and stratified by Index of Multiple Deprivation (IMD)
quintile in the older-onset colorectal cancer cohort.
aAdjusted for age, gender, English region and tumour
location. bThe chi-square test for heterogeneity of odds
ratios was used to assess for interaction in the
unadjusted analysis of ethnicity stratified by IMD quin-
tile for each ethnic group. The likelihood ratio test was
used to assess interaction in the adjusted analysis by
comparing logistic regression models with and without
an interaction term for ethnicity–IMD quintile and
thus, only one P-value has been presented.
Table S7. Logistic regression model of demographic
factors associated with advanced stage presentation,
defined as Stages I/II versus Stages III/IV, in the
older-onset colorectal cancer cohort after multiple
imputation of stage.
Table S8. Logistic regression model of demographic
factors associated with advanced stage presentation,
defined as Stages I/II/III versus Stage IV, in the older-
onset colorectal cancer cohort.
Table S9. Logistic regression model of demographic
factors associated with advanced stage presentation,
defined as Stage I versus Stages II/III/IV, in the older-
onset colorectal cancer cohort.
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